ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events Share: LinkedInTweet The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October 2, at which several of Signant’s clinical science and medicine leaders presented posters during the Scientific Program. The research they showcased represents the broad array of therapeutic area expertise at Signant and reflects our commitment advancing CNS clinical science. Peruse the posters below and learn more about some of the authors here. Monitoring of Scale Administration and Videography Improves Quality in a Study of a Rare Genetic Neuromuscular Disease Signant authors: Marcela Roy, Petra Reksoprodjo, Dorin Ariton, Ekaterina Ivanova, Joan Busner Download Poster Click to enlarge Positive and Negative Symptom Predominance in the Screening Period in Acute Schizophrenia Trials: An Exploratory Analysis Signant authors: Alan Kott, Xingmei Wang, David Daniel Download Poster Click to enlarge Impact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials Signant Authors: David S. Miller and Alan Kott Download Poster Click to enlarge Exploring Discordant Data in Dementia Clinical Trials Signant Authors: Alan Kott, David S. Miller Download Poster Click to enlarge Assessing the Severity of Anxiety Symptoms at Study Entry into Acute Schizophrenia Clinical Trials Signant Authors: David Daniel, Xingmei Wang, Alan KottDownload Poster Click to enlarge Borderline across Borderlines: Regional Variations in Who Enters Clinical Trials Signant Authors: Juliet Brown, Sayaka Machizawa, Rachel Berman, Gary SachsDownload Poster Click to enlarge Signant Health facebook twitter google-plus linkedin Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics. Recent Posts Data Analytics Clinical Trial Data: Navigating Audit Trail Data Regulations and Accessibility Challenges Apr 18, 2024 James Stringer Learn more eCOA Webinar Recap: Unleashing the Power of PROs Throughout Oncology Drug Development Feb 28, 2024 Signant Health Learn more eCOA 7 eCOA Solution Design Recommendations: Applied Insights from Trial Sites and CRAs Feb 12, 2024 Katie Garner Learn more General 5 Top Clinical Research Themes and Trends of 2023 (and 2024) Jan 02, 2024 Signant Health Learn more eCOA Webinar Recap: How EDC Can Support Modern Clinical Trials Dec 08, 2023 Signant Health Learn more
The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October 2, at which several of Signant’s clinical science and medicine leaders presented posters during the Scientific Program. The research they showcased represents the broad array of therapeutic area expertise at Signant and reflects our commitment advancing CNS clinical science. Peruse the posters below and learn more about some of the authors here. Monitoring of Scale Administration and Videography Improves Quality in a Study of a Rare Genetic Neuromuscular Disease Signant authors: Marcela Roy, Petra Reksoprodjo, Dorin Ariton, Ekaterina Ivanova, Joan Busner Download Poster Click to enlarge Positive and Negative Symptom Predominance in the Screening Period in Acute Schizophrenia Trials: An Exploratory Analysis Signant authors: Alan Kott, Xingmei Wang, David Daniel Download Poster Click to enlarge Impact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials Signant Authors: David S. Miller and Alan Kott Download Poster Click to enlarge Exploring Discordant Data in Dementia Clinical Trials Signant Authors: Alan Kott, David S. Miller Download Poster Click to enlarge Assessing the Severity of Anxiety Symptoms at Study Entry into Acute Schizophrenia Clinical Trials Signant Authors: David Daniel, Xingmei Wang, Alan KottDownload Poster Click to enlarge Borderline across Borderlines: Regional Variations in Who Enters Clinical Trials Signant Authors: Juliet Brown, Sayaka Machizawa, Rachel Berman, Gary SachsDownload Poster Click to enlarge Signant Health facebook twitter google-plus linkedin Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics.